I've watched CRISPR promise cures for a decade, but the only approved therapies target diseases affecting a few thousand people. Meanwhile, the cost of sequencing a genome dropped from $100 million to under $1,000. If biotech is so powerful, why hasn't it transformed common diseases like diabetes or Alzheimer's yet? Is the bottleneck really science, or is it our incentive systems and ethics?